Meta-analysis of the efficacy of moxifloxacin in treating Mycoplasma genitalium infection
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Mycoplasma genitalium is an important pathogen that is transmitted through sexual contact. For patients diagnosed with M. genitalium infection, the current guidelines recommend 1 g of azithromycin as the first-line treatment. Moxifloxacin is used as a second-line drug due to its remarkable efficacy; however, increased use of moxifloxacin to treat M. genitalium infections has caused the emergence of cases of moxifloxacin treatment failure. This meta-analysis aims to estimate the treatment efficacy of moxifloxacin for M. genitalium infection. Electronic databases were searched for articles published from 1983 to the end of May 2016 using the following search terms: ( Mycoplasma genitalium) AND (moxifloxacin OR 1-cyclopropyl–7-(2,8-diazabicyclo(4.3.0)non-8-yl)-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinoline carboxylic acid OR Proflox OR moxifloxacin hydrochloride OR Octegra OR Avelox OR Avalox OR Izilox OR Actira OR [treatment efficacy]). All included studies were published in English; all participants were diagnosed with M. genitalium infection, and microbial cure times were measured within 12 months after treatment. Treatment efficacy was measured as microbial cure at the final follow-up after treatment. In total, 17 studies including 252 participants met the inclusion criteria. The majority of these studies were observational. The random-effects pooled microbial cure rate was 96% (95% confidence interval [CI], 90%–99%; I 2 = 28.59%, P = 0.13). For studies with sample collection deadlines prior to 2010, the pooled microbial cure rate was 100% (95% CI, 99%–100%; I 2 = 0.00%, P = 1.00). For studies with sample collection deadlines of 2010 and later, the pooled microbial cure rate was 89% (95% CI, 82%–94%; I 2 = 0.00%, P = 0.59). The elimination rate of moxifloxacin for M. genitalium infection has decreased from 100% to 89% since 2010. This decline merits considerable attention. We suggest close follow-up to investigate the efficacy of moxifloxacin for treating M. genitalium infections. Additionally, sentinel points should be established to detect mutations in the gyrA/B and parC/E genes, which are associated with moxifloxacin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PRISMA-P Group, Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015) · Systematic Reviews · doi:10.1186/2046-4053-4-1 · Cited by 26,223
Sanderson, S., Tatt, I. D., & Higgins, J. P. (2007) · International Journal of Epidemiology · doi:10.1093/ije/dym018 · Cited by 1,531 · cited 2×
“Within-study bias for observational studies was assessed according to the evaluation criteria adopted by Sanderson et al.18 in a systematic review of tools used to evaluate bias in observational studies.”
MethodBissessor, M., Tabrizi, S. N., Bradshaw, C. S., Fairley, C. K., Hocking, J. S., Garland, S. M., Twin, J., Poljak, M., Peel, J., & Chen, M. Y. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.11.016 · Cited by 99
Guschin, A., Ryzhikh, P., Rumyantseva, T., Gomberg, M., & Unemo, M. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0781-7 · Cited by 97
Cited by
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 3,018
Machalek, D. A., Tao, Y., Shilling, H., Jensen, J. S., Unemo, M., Murray, G., Chow, E. P. F., Low, N., Garland, S. M., Vodstrcil, L. A., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30154-7 · Cited by 273
Read, T. R. H., Fairley, C. K., Murray, G. L., Jensen, J. S., Danielewski, J., Worthington, K., Doyle, M., Mokany, E., Tan, L., Chow, E. P. F., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy477 · Cited by 216
“Furthermore, a meta-analysis has shown a decline in cure for moxifloxacin from 100% in studies prior to 2010, to 89% in studies from 2010 onward [14].”
Result
Metadata
- Authors
- Li, Y., Le, W.-J., Li, S., Cao, Y.-P., & Su, X.-H.
- Venue
- International Journal of STD & AIDS
- Publisher
- SAGE Publications
- Published
- 2017-01-24
- Volume
- 28
- Issue
- 11
- Pages
- 1106-1114
- ISSN
- 0956-4624 (ISSN-L)
- 1758-1052
- OpenAlex
- W2581711863
- Cited by
- 78
- References
- 4
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Meta-analysis of the efficacy of moxifloxacin in treating Mycoplasma genitalium infection. https://app.cochat.ai/papers/10.1177/0956462416688562
- The paper
- Li, Y., Le, W.-J., Li, S., Cao, Y.-P., & Su, X.-H. (2017). Meta-analysis of the efficacy of moxifloxacin in treating Mycoplasma genitalium infection. International Journal of STD & AIDS. https://doi.org/10.1177/0956462416688562
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.